Cargando...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
"Consilium Medicum" Publishing house
2013-01-01
|
| Series: | Терапевтический архив |
| Assuntos: | |
| Acceso en liña: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|